NEWARK, Calif., Feb. 24 /PRNewswire/ -- Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that Noridian Administrative Services, LLC, a regional Medicare carrier administering benefits in nine states, is now covering the non-surgical Renessa treatment for women with stress urinary incontinence (SUI). Noridian currently administers benefits for approximately 4 million Medicare beneficiaries in Alaska, Arizona, Montana, North and South Dakota, Oregon, Utah, Washington and Wyoming.
According to Noridian's website, the insurer "will now cover CPT 0193T, transurethral, radiofrequency micro-remodeling of the female bladder neck and proximal urethra for stress urinary incontinence. This includes the Renessa transurethral collagen radiofrequency denaturation procedure." The website goes on to state that "coverage will be allowed when the procedure is performed consistent with FDA labeling and in accordance with the indications supported by peer-reviewed literature." The policy specifies that coverage only applies to cases of moderate to severe female SUI.
"We are very pleased with Noridian's decision," said Debra Reisenthel, Novasys Medical President and Chief Executive Officer. "Noridian is the first regional Medicare carrier to offer coverage for the Renessa procedure, and joins other private insurers, including Aetna US Healthcare, in providing coverage for this safe and effective non-surgical treatment for women who suffer from the debilitating effects of SUI," she continued.
Female Stress Urinary Incontinence
SUI is the involuntary leakage of urine associated with laughing,
coughing, sneezing and recreational activities. The condition is caused by a
variety of factors, most commonly childbirth, and often restricts the social,
professional, and personal lives of a significant number of women. With
currently available surgical and no
|SOURCE Novasys Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved